Celebrating innovation in women’s health and scientific leadership.
Our CEO, Agnès Arbat, has been awarded by the European Investment Bank (EIB) at BIO-EUROPE® 2025 in Vienna as the winner of the Open Call for Advancing Innovation in Women’s Health.
This recognition highlights her pioneering work in PCOS treatment and her unwavering commitment to addressing critical unmet needs in women’s health.
At Oxolife, our mission is clear: to revolutionize the PCOS journey by targeting its root cause, through groundbreaking innovations like OXO-001, with the potential for a transformative global health impact.
We thank the EIB for spotlighting female-led biotech innovation. The Women Leaders in Life Sciences panel was truly inspiring — voices that strengthen our commitment to advancing women’s health.
As the EIB powerfully stated:
“The gap in women’s health remains critical, with an urgent need for tailored solutions to accelerate progress.”
Let’s keep pushing forward!
More information: https://lnkd.in/dxcFAQjt